‌

US Patent 12077555 STAT degraders and uses thereof

Patent 12077555 was granted and assigned to Kymera Therapeutics on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Kymera Therapeutics

0

Current Assignee

Kymera Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Yi Zhang0

Bin Yang0

Nello Mainolfi0

Nan Ji0

Date of Patent

September 3, 2024

0

Patent Application Number

177366690

Date Filed

May 4, 2022

0

Patent Citations

US Patent 7208157 Proteolysis targeting chimeric pharmaceutical

0

US Patent 7273920 Controlling protein levels in eucaryotic organisms

0

US Patent 7307077 Heterocyclic compound and antitumor agent containing the same as effective ingredient

0

US Patent 7390799 Apoptosis promoters

0

US Patent 7402325 Supercritical carbon dioxide extract of pharmacologically active components from

0

US Patent 7449458 Prodrugs of 2,4-pyrimidinediamine compounds and their uses

0

US Patent 7501496 Anti-OX40L antibodies

0

US Patent 7514444 Inhibitors of bruton's tyrosine kinase

0

...

Patent Primary Examiner

0

Patent abstract

The present invention provides compounds, compositions thereof, and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12077555 STAT degraders and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.